These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Letter to the editor: Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor. Yuksel N Graefes Arch Clin Exp Ophthalmol; 2021 Dec; 259(12):3819. PubMed ID: 34292393 [No Abstract] [Full Text] [Related]
11. [Vismodegib in metastasized basal cell carcinoma]. Reinders MG; Dirix L; Mosterd K; van Doorn R Ned Tijdschr Geneeskd; 2013; 157(12):A6011. PubMed ID: 23515044 [TBL] [Abstract][Full Text] [Related]
12. Four-year experience with vismodegib hedgehog inhibitor therapy. Simone PD; Schwarz JM; Strasswimmer JM J Am Acad Dermatol; 2016 Jun; 74(6):1264-5. PubMed ID: 27185433 [No Abstract] [Full Text] [Related]
13. Vismodegib (Erivedge) for basal cell carcinoma. Med Lett Drugs Ther; 2012 Jul; 54(1394):53-4. PubMed ID: 22777303 [No Abstract] [Full Text] [Related]
14. Practical management of the adverse effects of Hedgehog pathway inhibitor therapy for basal cell carcinoma. Jacobsen AA; Kydd AR; Strasswimmer J J Am Acad Dermatol; 2017 Apr; 76(4):767-768. PubMed ID: 28325399 [No Abstract] [Full Text] [Related]
15. Following the hedgehog to new cancer therapies. Dlugosz AA; Talpaz M N Engl J Med; 2009 Sep; 361(12):1202-5. PubMed ID: 19726764 [No Abstract] [Full Text] [Related]
16. Efficacy of Hedgehog pathway inhibitors in Basal cell carcinoma. Basset-Seguin N; Sharpe HJ; de Sauvage FJ Mol Cancer Ther; 2015 Mar; 14(3):633-41. PubMed ID: 25585509 [TBL] [Abstract][Full Text] [Related]